Relationship between Maternal Fever and Neonatal Sepsis: A Retrospective Study at a Medical Center
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Population
2.2. Data Collected from the Newborns
2.3. Data Collected from the Mothers
2.4. Diagnosis
2.5. Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Liu, L.; Johnson, H.L.; Cousens, S.; Perin, J.; Scott, S.; Lawn, J.E.; Rudan, I.; Campbell, H.; Cibulskis, R.; Li, M.; et al. Global, Regional, and National Causes of Child Mortality: An Updated Systematic Analysis for 2010 With Time Trends Since 2000. Lancet 2012, 379, 2151–2161. [Google Scholar] [CrossRef]
- Oza, S.; Lawn, J.E.; Hogan, D.R.; Mathers, C.; Cousens, S.N. Neonatal Cause-of-Death Estimates for the Early and Late Neonatal Periods for 194 Countries: 2000–2013. Bull. World Health Organ. 2015, 93, 19–28. [Google Scholar] [CrossRef] [PubMed]
- American Academy of Pediatrics. Group B Streptococcal Infections. In Report of the Committee on Infectious Diseases, 31st ed.; Book, R., Kimberlin, D.W., Brady, M.T., Jackson, M.A., Long, S.S., Eds.; American Academy of Pediatrics: Itasca, IL, USA, 2018; p. 762. [Google Scholar]
- Centers for Disease Control and Prevention (CDC). Perinatal Group B Streptococcal Disease After Universal Screening Recommendations—United States, 2003–2005. MMWR Morb. Mortal. Wkly Rep. 2007, 56, 701–705. [Google Scholar]
- Centers for Disease Control and Prevention (CDC). Trends in Perinatal Group B Streptococcal Disease—United States, 2000–2006. MMWR Morb. Mortal. Wkly Rep. 2009, 58, 109–112. [Google Scholar]
- Puopolo, K.M.; Benitz, W.E.; Zaoutis, T.E.; Committee on Fetus and Newborn; Committee on Infectious Diseases. Management of Neonates Born at ≥35 0/7 Weeks’ Gestation with Suspected or Proven Early-Onset Bacterial Sepsis. Pediatrics 2018, 142, e20182894. [Google Scholar] [CrossRef]
- Escobar, G.J.; Li, D.K.; Armstrong, M.A.; Gardner, M.N.; Folck, B.F.; Verdi, J.E.; Xiong, B.; Bergen, R. Neonatal Sepsis Workups in Infants ≥ 2000 Grams at Birth: A Population-Based Study. Pediatrics 2000, 106, 256–263. [Google Scholar] [CrossRef]
- Puopolo, K.M.; Draper, D.; Wi, S.; Newman, T.B.; Zupancic, J.; Lieberman, E.; Smith, M.; Escobar, G.J. Estimating the Probability of Neonatal Early-Onset Infection on the Basis of Maternal Risk Factors. Pediatrics 2011, 128, e1155–e1163. [Google Scholar] [CrossRef] [PubMed]
- Ashwal, E.; Salman, L.; Tzur, Y.; Aviram, A.; Ben-Mayor Bashi, T.; Yogev, Y.; Hiersch, L. Intrapartum Fever and the Risk for Perinatal Complications—The Effect of Fever Duration and Positive Cultures. J. Matern. Fetal Neonatal Med. 2018, 31, 1418–1425. [Google Scholar] [CrossRef] [PubMed]
- Dior, U.P.; Kogan, L.; Eventov-Friedman, S.; Gil, M.; Bahar, R.; Ergaz, Z.; Porat, S.; Calderon-Margalit, R. Very High Intrapartum Fever in Term Pregnancies and Adverse Obstetric and Neonatal Outcomes. Neonatology 2016, 109, 62–68. [Google Scholar] [CrossRef]
- Hornik, C.P.; Benjamin, D.K.; Becker, K.C.; Benjamin, D.K., Jr.; Li, J.; Clark, R.H.; Cohen-Wolkowiez, M.; Smith, P.B. Use of the Complete Blood Cell Count in Early-Onset Neonatal Sepsis. Pediatr. Infect. Dis. J. 2012, 31, 799–802. [Google Scholar] [CrossRef]
- Murphy, K.; Weiner, J. Use of Leukocyte Counts in Evaluation of Early-Onset Neonatal Sepsis. Pediatr. Infect. Dis. J. 2012, 31, 16–19. [Google Scholar] [CrossRef] [PubMed]
- Iroh Tam, P.Y.I.; Bendel, C.M. Diagnostics for Neonatal Sepsis: Current Approaches and Future Directions. Pediatr. Res. 2017, 82, 574–583. [Google Scholar] [CrossRef]
- Saboohi, E.; Saeed, F.; Khan, R.N.; Khan, M.A. Immature to Total Neutrophil Ratio as an Early Indicator of Early Neonatal Sepsis. Pak. J. Med. Sci. 2019, 35, 241–246. [Google Scholar] [CrossRef]
- Monica, L.; Riti, J.S.; Amit, B.K. Role of Sepsis Screen Parameters in Early Diagnosis of Neonatal Septicemia. Int. J. Curr. Microbiol. App. Sci. 2018, 7, 2410–2419. [Google Scholar] [CrossRef]
- Newman, T.B.; Puopolo, K.M.; Wi, S.; Draper, D.; Escobar, G.J. Interpreting Complete Blood Counts Soon After Birth in Newborns at Risk for Sepsis. Pediatrics 2010, 126, 903–909. [Google Scholar] [CrossRef]
- Kuhn, P.; Dheu, C.; Bolender, C.; Chognot, D.; Keller, L.; Demil, H.; Donato, L.; Langer, B.; Messer, J.; Astruc, D. Incidence and Distribution of Pathogens in Early-Onset Neonatal Sepsis in the Era of Antenatal Antibiotics. Paediatr. Perinat. Epidemiol. 2010, 24, 479–487. [Google Scholar] [CrossRef]
- Chacko, B.; Sohi, I. Early Onset Neonatal Sepsis. Indian J. Pediatr. 2005, 72, 23–26. [Google Scholar] [CrossRef]
- Stoll, B.J.; Puopolo, K.M.; Hansen, N.I.; Sánchez, P.J.; Bell, E.F.; Carlo, W.A.; Cotten, C.M.; D’Angio, C.T.; Kazzi, S.N.J.; Poindexter, B.B.; et al. Early-Onset Neonatal Sepsis 2015 to 2017, the Rise of Escherichia coli, and the Need for Novel Prevention Strategies. JAMA Pediatr. 2020, 174, e200593. [Google Scholar] [CrossRef]
- Verani, J.R.; McGee, L.; Schrag, S.J.; Division of Bacterial Disease, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of Perinatal Group B Streptococcal Disease—Revised Guidelines From CDC, 2010. MMWR Recomm. Rep. 2010, 59, 1–36. [Google Scholar]
- Shane, A.L.; Sánchez, P.J.; Stoll, B.J. Neonatal Sepsis. Lancet 2017, 390, 1770–1780. [Google Scholar] [CrossRef]
- Belachew, A.; Tewabe, T. Neonatal Sepsis and Its Association with Birth Weight and Gestational Age Among Admitted Neonates in Ethiopia: Systematic Review and Meta-analysis. BMC Pediatr. 2020, 20, 55. [Google Scholar] [CrossRef] [PubMed]
- Sharpe, E.E.; Arendt, K.W. Epidural Labor Analgesia and Maternal Fever. Clin. Obstet. Gynecol. 2017, 60, 365–374. [Google Scholar] [CrossRef] [PubMed]
- Jansen, S.; Lopriore, E.; Naaktgeboren, C.; Sueters, M.; Limpens, J.; van Leeuwen, E.; Bekker, V. Epidural-Related Fever and Maternal and Neonatal Morbidity: A Systematic Review and Meta-analysis. Neonatology 2020, 117, 259–270. [Google Scholar] [CrossRef]
- Wassen, M.M.; Winkens, B.; Dorssers, E.M.; Marcus, M.A.; Moonen, R.M.; Roumen, F.J. Neonatal Sepsis Is Mediated by Maternal Fever in Labour Epidural Analgesia. J. Obstet. Gynaecol. 2014, 34, 679–683. [Google Scholar] [CrossRef]
- Nijman, T.A.J.; Voogdt, K.G.J.A.; Teunissen, P.W.; van der Voorn, P.J.J.; de Groot, C.J.M.; Bakker, P.C.A.M. Association Between Infection and Fever in Terminations of Pregnancy Using Misoprostol: A Retrospective Cohort Study. BMC Pregnancy Childbirth 2017, 17, 7. [Google Scholar] [CrossRef] [PubMed]
- León, W.; Durocher, J.; Barrera, G.; Pinto, E.; Winikoff, B. Dose and Side Effects of Sublingual Misoprostol for Treatment of Postpartum Hemorrhage: What Difference Do They Make? BMC Pregnancy Childbirth 2012, 12, 65. [Google Scholar] [CrossRef]
- Maayan-Metzger, A.; Mazkereth, R.; Shani, A.; Kuint, J. Risk Factors for Maternal Intrapartum Fever and Short-Term Neonatal Outcome. Fetal Pediatr. Pathol. 2006, 25, 169–177. [Google Scholar] [CrossRef] [PubMed]
- Yancey, M.K.; Zhang, J.; Schwarz, J.; Dietrich, C.S., 3rd; Klebanoff, M. Labor Epidural Analgesia and Intrapartum Maternal Hyperthermia. Obstet. Gynecol. 2001, 98, 763–770. [Google Scholar] [CrossRef] [PubMed]
- Alexander, J.M.; McIntire, D.M.; Leveno, K.J. Chorioamnionitis and the Prognosis for Term Infants. Obstet. Gynecol. 1999, 94, 274–278. [Google Scholar] [CrossRef]
- G./Eyesus, T.; Moges, F.; Eshetie, S.; Yeshitela, B.; Abate, E. Bacterial Etiologic Agents Causing Neonatal Sepsis and Associated Risk Factors in Gondar, Northwest Ethiopia. BMC Pediatr. 2017, 17, 137. [Google Scholar] [CrossRef]
- Sorsa, A. Epidemiology of Neonatal Sepsis and Associated Factors Implicated: Observational Study at Neonatal Intensive Care Unit of Arsi University Teaching and Referral Hospital, South East Ethiopia. Ethiop. J. Health Sci. 2019, 29, 333–342. [Google Scholar] [CrossRef] [PubMed]
Unlikely Sepsis (n = 550) | Probable/Proven (n = 509) | p-Value | |||||
---|---|---|---|---|---|---|---|
Median | Q1 | Q3 | Median | Q1 | Q3 | ||
Maternal Factors Age Parity Prenatal misoprostol administration to fever time (h) Postpartum misoprostol administration to fever time (h) Prenatal epidural analgesia to fever time (h) Fever to birth time (h) From birth to fever time (h) Time point of first fever (h) (birth time as origin) Baby’s Factors Gestational age (week) Birth body weight (g) 1 min APGAR score Time of data from birth (h) Heart rate (beats/min) Respiratory rate (breaths/min) | 32.00 1.00 17.98 2.25 13.33 3.75 2.75 2.58 38.71 2989.00 8.00 3.37 152.00 55.00 | 29.00 1.00 10.47 1.50 8.28 1.37 2.08 1.52 37.71 2694.00 8.00 2.38 144.00 51.00 | 36.00 2.00 28.92 2.78 21.33 10.13 3.63 3.43 39.43 3254.00 8.00 4.75 158.00 58.00 | 32.00 1.00 17.44 1.81 14.42 3.41 2.40 1.77 38.86 3122.00 8.00 2.82 160.00 62.00 | 28.00 1.00 11.85 1.25 8.29 1.32 1.55 −0.63 38.00 2850.00 8.00 1.97 156.00 58.00 | 35.00 1.00 26.58 2.67 23.27 8.27 3.13 2.78 39.57 3378.00 8.00 3.97 163.00 66.00 | 0.175 <0.001 0.926 0.008 0.170 0.514 <0.001 <0.001 0.001 <0.001 0.001 <0.001 <0.001 <0.001 |
Microorganism | Maternal Fever Time Point | Time Interval between Fever and Birth (Min) | |
---|---|---|---|
Case 1 | Escherichia coli | postpartum fever | 149 |
Case 2 | Streptococcus agalactiae | postpartum fever | 142 |
Case 3 | Streptococcus gallolyticus ssp pasteurianus | intrapartum fever | 29 |
Case 4 | Bacillus cereus group | postpartum fever | 241 |
Unlikely | Probable/Proven | p-Value | ||||
---|---|---|---|---|---|---|
n (550) | % | n (509) | % | |||
Parity | 1 2 3 4 5 | 365 149 29 6 1 | 66.4 27.1 5.3 1.1 0.2 | 338 102 17 2 0 | 76.2 20.0 3.3 0.4 0.0 | 0.004 |
Delivery type | NSD C/S VED | 114 179 257 | 20.7 32.5 46.7 | 84 116 309 | 16.5 22.8 60.7 | <0.001 |
GBS screen | Negative Positive Unknown | 410 120 20 | 74.5 21.8 3.6 | 397 102 10 | 78.0 20.0 2.0 | 0.181 |
Chorioamnionitis | No Suspected Yes | 543 6 0 | 98.9 1.1 0 | 496 9 4 | 97.4 1.8 0.8 | 0.076 |
Time point of Misoprostol | No use Before delivery After delivery Use after fever | 234 141 163 12 | 42.5 25.6 29.6 2.2 | 188 177 127 17 | 36.9 34.8 25.0 3.3 | 0.005 |
Epidural analgesia in labor | No Yes Use after fever | 215 332 3 | 39.1 60.4 0.5 | 87 418 4 | 17.1 82.1 0.8 | <0.001 |
Intrapartum fever (38–38.9 °C) | No Yes | 477 73 | 86.7 13.3 | 367 142 | 72.1 27.9 | <0.001 |
Fever duration—intrapartum | <4 h 4–8 h 8–12 h >12 h | 40 18 9 6 | 54.8 24.7 12.3 8.2 | 86 25 17 14 | 60.6 17.6 12.0 9.9 | 0.656 |
Intrapartum fever (≥39 °C) | No Yes | 538 12 | 97.8 2.2 | 480 29 | 94.3 5.7 | 0.003 |
Postpartum fever (38–38.9 °C) | No Yes | 63 487 | 11.5 88.5 | 129 380 | 25.3 74.7 | <0.001 |
Fever duration—postpartum | <4 h 4–8 h 8–12 h >12 h | 410 62 8 7 | 84.2 12.7 1.6 1.4 | 321 44 7 8 | 84.5 11.6 1.8 2.1 | 0.842 |
Postpartum fever (≥39 °C) | No Yes | 465 85 | 84.5 15.5 | 451 58 | 88.6 11.4 | 0.053 |
Preterm | No Yes | 476 74 | 86.5 13.5 | 477 32 | 93.7 6.3 | <0.001 |
APGAR score −1 min | ≥7 <7 | 547 3 | 99.5 0.5 | 496 13 | 97.4 2.6 | 0.010 |
PROM > 18 h | No Yes | 533 17 | 96.9 3.1 | 466 43 | 91.6 8.4 | <0.001 |
Fever time point | Intrapartum Postpartum Intra- and postpartum | 63 477 10 | 11.5 86.7 1.8 | 129 367 13 | 25.3 72.1 2.6 | <0.001 |
Bivariable Analysis (Crude) | Multivariable Analysis (Adjusted) | |||||
---|---|---|---|---|---|---|
Odds Ratio | 95% CI | p-Value | Odds Ratio | 95% CI | p-Value | |
Parity | 0.681 | 0.553–0.839 | <0.001 | |||
Time point of Misoprostol No use Before delivery After delivery Use after fever | 1.000 1.562 0.970 1.763 | 1.166–2.094 0.718–1.311 0.822–3.784 | 0.003 0.842 0.145 | |||
Epidural analgesia in labor No Yes Use after fever | 1.000 3.111 3.295 | 2.333–4.149 0.722–15.028 | <0.001 0.124 | 1.000 3.398 2.177 | 2.355–4.902 0.352–13.468 | <0.001 0.403 |
Delivery type NSD C/S VED | 1.000 0.879 1.632 | 0.610–1.268 1.177–2.262 | 0.492 0.003 | |||
Intrapartum fever (38–38.9°C) No Yes | 1.000 2.528 | 1.848–3.459 | <0.001 | |||
Maternal fever time point Intrapartum Postpartum Intra- and post-partum fever | 1.000 0.376 0.635 | 0.270–0.523 0.264–1.527 | <0.001 0.310 | 1.000 0.661 0.969 | 0.439–0.994 0.341–2.750 | 0.047 0.953 |
APGAR score −1 min ≥7 <7 | 1.000 4.779 | 1.354–16.869 | 0.015 | |||
PROM >18 h No Yes | 1.000 2.893 | 1.628–5.142 | <0.001 | |||
Heart rate | 1.148 | 1.125–1.172 | <0.001 | |||
Respiratory rate | 1.235 | 1.200–1.270 | <0.001 | 1.230 | 1.194–1.267 | <0.001 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Huang, S.-H.; Chang, Y.-J.; Chen, L.-J.; Lee, C.-H.; Chen, H.-N.; Chen, J.-Y.; Hsiao, C.-C. Relationship between Maternal Fever and Neonatal Sepsis: A Retrospective Study at a Medical Center. Biomedicines 2022, 10, 2222. https://doi.org/10.3390/biomedicines10092222
Huang S-H, Chang Y-J, Chen L-J, Lee C-H, Chen H-N, Chen J-Y, Hsiao C-C. Relationship between Maternal Fever and Neonatal Sepsis: A Retrospective Study at a Medical Center. Biomedicines. 2022; 10(9):2222. https://doi.org/10.3390/biomedicines10092222
Chicago/Turabian StyleHuang, Sheng-Hua, Yu-Jun Chang, Lih-Ju Chen, Cheng-Han Lee, Hsiao-Neng Chen, Jia-Yuh Chen, and Chien-Chou Hsiao. 2022. "Relationship between Maternal Fever and Neonatal Sepsis: A Retrospective Study at a Medical Center" Biomedicines 10, no. 9: 2222. https://doi.org/10.3390/biomedicines10092222
APA StyleHuang, S. -H., Chang, Y. -J., Chen, L. -J., Lee, C. -H., Chen, H. -N., Chen, J. -Y., & Hsiao, C. -C. (2022). Relationship between Maternal Fever and Neonatal Sepsis: A Retrospective Study at a Medical Center. Biomedicines, 10(9), 2222. https://doi.org/10.3390/biomedicines10092222